Ben Gaffikin

Partner

Filter by:

News 16 December 2024

McCann FitzGerald LLP advises the management team of WaterWipes in connection with…

Read more
Knowledge 27 November 2024

A guide to European Long-Term Investment Funds

Read more
News 26 April 2022

McCann FitzGerald LLP Advises Fulfil Nutrition on its sale to The Ferrero Group

Read more
News 31 January 2022

McCann FitzGerald LLP advises Willis Towers Watson and AMX on sale of AMX to Carne

Read more
News 12 January 2022

McCann FitzGerald LLP advises PEAL Capital Partners on Establishment of new ILP

Read more
News 11 November 2021

McCann FitzGerald LLP Advises BidX1 on Strategic Growth Investments from doValue…

Read more
News 8 July 2021

McCann FitzGerald Advises Capitalflow on its Sale to bunq

Read more
News 1 June 2021

McCann FitzGerald Advises Beauparc on its Sale to Macquarie

Read more
Knowledge 18 February 2021

The Irish Investment Limited Partnership - a modern and flexible option for private…

Read more
News 2 November 2020

McCann FitzGerald Advises IPL on its Acquisition by Madison Dearborn Partners

Read more
Knowledge 15 September 2020

The International Comparative Legal Guide to Private Equity 2020

Read more
News 20 May 2020

McCann FitzGerald Advises CarTrawler on €100 Million Investment

Read more
News 25 February 2020

McCann FitzGerald advises the shareholders of Dubray Books on its sale to Eason

Read more
News 31 October 2018

McCann FitzGerald advises Novo Nordisk on its Acquisition of U.S. and Canadian Rights…

Read more
News 29 August 2018

McCann FitzGerald advises Adapt Pharma and its Shareholders on its Sale to Emergent…

Read more
News 16 December 2016

McCann FitzGerald advise IAMSA Group on its acquisition of a 49 per cent stake in…

Read more
News 16 September 2016

McCann FitzGerald advises AmDocs on its acquisition of Brite:Bill

Read more
News 21 April 2015

McCann FitzGerald advises Horizon Pharma plc in relation to its US$475 million share…

Read more
News 30 March 2015

McCann FitzGerald advising Horizon Pharma on proposed $1.1 billion acquisition of…

Read more
News 13 March 2015

McCann FitzGerald advises Horizon Pharma plc on its $400 million Exchangeable Senior…

Read more